Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older at the time the graft is placed
- People who have been diagnosed with end-stage kidney disease or serious kidney problems that require hemodialysis (a machine-based blood-cleaning treatment)
- People who need a new way to access their bloodstream to start or continue dialysis, and for whom an AV (arteriovenous) access graft is considered a suitable option by their doctor
- People who are able to understand the study requirements and sign a consent form — either themselves or through a legal guardian
- People who have agreed to allow their health information to be used for the purposes of this study
Who may not be able to join:
- People who are currently taking part in another clinical trial involving an experimental drug or medical device
- People who have a known allergy or sensitivity to certain antibiotics (such as Lincomycin, Polymyxin B, Ciprofloxacin, Meropenem, Gentamicin, or Vancomycin) or to certain chemicals used in making the study product (such as N-lauroyl sarcosine, Denarase, or glycerol/glycerin)
- People with a history of serious heart disease, a heart attack within the past 6 months, dangerous heart rhythm problems, or ongoing unstable chest pain requiring treatment
- People with a history of severe blood vessel disease in the arms
- People who are unable or unwilling to attend all required study visits
- People who have any other condition that the study doctor believes could put them at undue risk or affect the reliability of the study results
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 757-609-4378
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
UltraSound evaluation of allograft functional patency.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.